Advertisement
U.S. markets closed

ViaDerma, Inc. (VDRM)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0126-0.0005 (-3.46%)
At close: 03:15PM EDT

ViaDerma, Inc.

4640 Admiralty Way
Suite 500
Marina del Rey, CA 90292
United States
310 496 5744
https://viadermalicensing.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Qing Hua LinChief Financial Officer and Director4.46kN/A1981
Mr. Baotang ZhaoChief Sales Officer28.77kN/A1978
Mr. Zhang XieCorporate Secretary and Director9.18kN/A1979
Dr. Christopher A OtikoFounder, Chief Executive Officer and PresidentN/AN/AN/A
Dr. Andrew Berman M.D., MPHMedical Director and Member of Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.

Corporate Governance

ViaDerma, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.